Skip to main content

This job has expired

You will need to login before you can apply for a job.

Director/Senior Director, Clinical Pharmacology and Pharmacometrics

Employer
Obsidian Therapeutics
Location
Cambridge, MA
Start date
Oct 1, 2022

View more

Discipline
Clinical, Clinical Research, Science/R&D, Pharmacology
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Genetown

Job Details

Director/Senior Director, Clinical Pharmacology and Pharmacometrics

Cambridge, MA

About Us…

Obsidian Therapeutics is pioneering engineered cell and gene therapies to deliver transformative outcomes for patients. Obsidian’s programs apply our CytoDriveTM technology in Cell and Gene therapy products to control expression of proteins for enhanced therapeutic efficacy and safety. Obsidian’s lead program is currently in clinical development. We recently received our IND clearance from FDA to begin our first clinical trial for the treatment of patients with metastatic melanoma.

We’re proud of our diverse talented team and committed to cultivating an environment of inclusion where each person feels a strong sense of belonging and is supported to continuously learn and contribute their best work. Our research team is based in the heart of Cambridge, MA, and our Technical Development, Manufacturing & Quality team is based in our brand new facility in Bedford, MA to support our growth.  Obsidianites enjoy a highly collaborative culture, competitive salary and benefits, and potential for ownership through stock options.

Our Opportunity… 

We’re looking for a Clinical Pharmacologist with a strong background in cell therapy and gene editing to contribute to building Obsidian’s clinical and translational pharmacokinetic and pharmacodynamic (PK/PD) capabilities. In this role, you’ll work collaboratively with members of our clinical, translational, and cell therapy teams to lead the clinical and pre-clinical investigation of pharmacokinetic and pharmacodynamic (PK/PD) relationships for novel regulated cell therapies.

As part of our Translational Early Clinical Development group, you’ll be a vital part of a highly collaborative team working to achieve Obsidian’s vision by translating innovative science into medical breakthroughs for patients, starting with our lead program OBX-115, engineered to make TILs more effective for more patients. 

This is a unique opportunity to be a contributor in a well-funded clinical company with blue chip investors, field-leading advisors, best-in-class partners (BMS and Vertex), and an experienced team. You'll help us build a dynamic, innovative, passionate, collaborative, and successful organization focused on delivering transformative therapies in areas of greatest clinical need. 

You Will… 

  • Integrate pharmacokinetic and pharmacology expertise to support clinical and preclinical activities for our lead and exploratory programs, including regulated, engineered tumor infiltrating lymphocytes (TILs) and gene-edited T cell therapies.
  • Support pre-IND activities including FIH dose selection.
  • Collaborate cross-functionally with Research/Biometric/Bioinformatics/Clinical/Translational team to analyze and integrate PKPD and activity readouts to inform dose optimization, dose-escalation/expansion and RP2D decisions.
  • Lead the execution of clinical pharmacology studies.
  • Author and review documents like clinical protocols, and regulatory submissions such as briefing documents, INDs, IB, clinical study reports, CTAs and NDAs.
  • Manage external vendors to support pharmacometric and population-based PK/PD modeling efforts.
  • Maintain current knowledge of the field and area(s) of scientific and technical expertise and development.

You Bring… 

Core Qualifications 

  • A PhD degree in Pharmacokinetics, Pharmaceutical Sciences, Pharmacology, Applied Mathematics, or a related discipline, and 10 +/- years of related clinical pharmacology experience.
  • Strong knowledge of drug development and FDA and ICH guidance documents.
  • Experience managing external service providers and CRO’s with timely delivery of clear, accurate and well-written study findings required. 
  • Proficiency with hands-on data analysis, modelling, and reporting using Phoenix WinNonLin, MatLAB, Rstudio, NonMem, or equivalent.
  • Strong knowledge of and user competency in additional common software and data analysis packages (e.g., Microsoft Office Suite, SoftMax Pro, GraphPad Prism, JMP).
  • Self-motivation and a proven ability to work with general direction to meet objectives and timelines.
  • A desire and ability to work in an entrepreneurial, collaborative environment. You build healthy, productive, and high trust relationships within your function and with direct stakeholders, invite and share feedback and ideas, and effectively influence actions and decisions.
  • Flexibility, you readily adapt to changes and priorities in order to fulfill our mission.
  • Strong technical writing and scientific skills.
  • Solid project management skills and experience managing complex projects.
  • Excellent communication skills.

Bonus Qualifications 

  • Strong knowledge and experience of cell therapy and gene editing platforms. 
  • Prior experience in clinical oncology and with engineered and gene edited T cell therapy platforms
  • Prior experience with small molecule-based clinical pharmacology.

Work location:  Hybrid (Cambridge, MA)

Obsidian is proud to be an equal opportunity employer, cultivating a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, veteran status or any other applicable legally protected characteristics.

Company

Obsidian Therapeutics is pioneering engineered cell and gene therapies to deliver transformative outcomes for patients for the treatment of cancer and other diseases. Obsidian’s programs apply our CytoDRiVETM technology in Cell and Gene therapy products to control expression of proteins for enhanced therapeutic efficacy and safety. Obsidians’ lead program is currently in clinical development for the treatment of patients with metastatic melanoma and other solid tumors.


Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partnerships with industry leaders, and a highly experienced, dynamic, innovative and collaborative team, collectively focused on delivering transformative therapies in areas of greatest clinical need.


We’re proud of our diverse talented team and committed to cultivating an environment where each person feels a strong sense of belonging and is supported to continuously learn and contribute their best work. Our research team is based in the heart of Cambridge, MA, and our Technical Development, Manufacturing & Quality team is based in our new facility in Bedford, MA. We offer competitive salary and benefits, and potential for employee ownership through stock options.
 

x twitter new logo [square]

Company info
Website
Phone
(781) 806-6245
Location
1030 Massachusetts Avenue
Cambridge
Massachusetts
02138
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert